Colorectal Cancer News and Research

Latest Colorectal Cancer News and Research

Statin drugs prescribed for heart disease also reduce the risk of colon cancer

According to new research released this week people taking statin drugs to control the progression of heart disease may be getting the extra benefit of protection from colorectal cancer.

25 May 2005

Risks outweigh benefits of shark cartilage as anti-cancer treatment

As a treatment for advanced cancer, shark cartilage fails to benefit patients and its adverse effects lead to poor compliance.

23 May 2005

Cetuximab (Erbitux) can battle cancer and prolong life in many patients with advanced colorectal cancer

"Even in people who have gone through six or more previous courses of chemotherapy, cetuximab, may fight the growth of cancer, giving patients additional months of life," says study presenter Heinz-Josef Lenz, M.D., associate professor of medicine at the Keck School of Medicine of the University of Southern California and USC/Norris Comprehensive Cancer Center.

20 May 2005

Sigmoidoscopy comes up short for women in detection of polyps in the colon

A new multi-center study has reaffirmed the difference between the sexes – at least when it comes to colorectal cancer detection and prevention.

20 May 2005

Smoking may have a devastating effect on gastrointestinal health

Smoking may have a devastating effect on gastrointestinal health and increase a person's risk of developing pancreatic and liver cancer, according to new research presented today at Digestive Disease Week 2005 (DDW). Furthermore, data from the Nurses' Health Study shows that meat intake and smoking play a part in significantly increasing a woman's risk of colorectal cancer.

17 May 2005

Statin chemoprevention with minimal surveillance could prevent 96 percent of colon cancers

Ulcerative colitis affects about one out of every 2,000 Americans, and after living with the disease for 30 years, nearly 22 percent of those people will develop colon cancer.

16 May 2005

Accuracy of CT colonography is excellent in comparison with conventional colonoscopy for colorectal cancer screening

The diagnostic accuracy of CT colonography is excellent in comparison with conventional colonoscopy for colorectal cancer screening, an analysis of previous studies shows.

16 May 2005

Genetic biomarker that may improve quality of life during treatment for colorectal cancer

A Mayo Clinic-led study has revealed a genetic biomarker that can predict which patients are most likely to experience unwanted side effects from one of the most commonly used and highly effective chemotherapy regimens designed to treat colorectal cancer.

16 May 2005

Bevacizumab plus chemo extends survival beyond one year for large group of advanced lung cancer patients

Patients with a particular type of advanced lung cancer may have a new option based on data presented at the 2005 annual meeting of the American Society of Clinical Oncology showing that combining a drug that cuts off the cancer's blood supply with standard chemotherapy can shrink tumors and extend life.

15 May 2005

After surgery check colon tumors for signs of syndrome, study suggests

A new study suggests that, after surgery, all colon tumors should be tested to learn if the patient may have an inherited syndrome that carries an extremely high risk of cancer. It also suggests that this prescreening can be done using a relatively inexpensive microscopy test already used in hospital pathology laboratories.

5 May 2005

Scientists use tobacco plants to create antibodies against tumor cells

Scientists at Jefferson Medical College are using tobacco plants to produce monoclonal antibodies – tiny guided protein missiles – that can target and hunt down cancer cells. The plants promise to provide a cheaper, faster method of producing anticancer antibodies, raising hopes that the technology can one day be used in humans.

3 May 2005

Gene variant that increases colon cancer risk

A paper published in this week's Journal of Clinical Oncology says Transforming Growth Factor Beta Receptor 1*6A (TGFBR1*6A) - a mutated gene present in nearly one in eight people and the most commonly inherited cancer susceptibility gene identified so far - might be responsible for a significant proportion of familial colorectal cancers.

2 May 2005

Blocking the COX-1 enzyme might be the answer in ovarian cancer treatment

Researchers at Vanderbilt University Medical Center in a new report say that blocking the COX-1 enzyme - not COX-2 - might lead to a way to prevent and treat the most common and fatal form of ovarian cancer.

2 May 2005

Blocking the COX-1 enzyme might prevent and treat the most common and fatal form of ovarian cancer

Blocking the COX-1 enzyme - not COX-2 - might lead to a way to prevent and treat the most common and fatal form of ovarian cancer, researchers at Vanderbilt University Medical Center reported this week.

1 May 2005

Revised Bethesda guidelines effective at identifying patients at risk of colorectal cancer

The revised Bethesda guidelines, used for screening patients for a type of hereditary colorectal cancer, are effective for determining which patients should undergo further genetic testing, according to a study in the April 27 issue of JAMA.

26 Apr 2005

Hereditary colorectal cancer risk lowered in those without certain gene defect

Families with a certain type of hereditary colorectal cancer have a reduced cancer risk if they do not have a gene defect found in many with this type of cancer risk, according to a study in the April 27 issue of JAMA.

26 Apr 2005

“Virtual Colonoscopy” effective in finding most polyps but may miss small ones

A type of noninvasive “virtual colonoscopy” can diagnose medium to large polyps as well as traditional colorectal probes can, but it may miss some smaller yet potentially cancerous growths, according to a new review of studies.

21 Apr 2005

ASTRO public awareness campaign wins award

The American Society for Therapeutic Radiology and Oncology’s public awareness campaign to educate cancer patients on their treatment options has won an Award of Distinction from The Communicator Awards in their 2005 Print Media competition. ASTRO also received Awards of Distinction for its quarterly magazine, ASTROnews, and its Annual Meeting Guide magazine supplement.

20 Apr 2005

Researchers determine structure of binding site of colon-cancer drug Erbitux and its protein target

Researchers at the University of Pennsylvania School of Medicine have determined the precise molecular details of how Erbitux, a recently approved colorectal cancer drug, binds to its target on cancer cells. Knowing this chemical configuration will lead to better drug design for this family of cancer medications.

19 Apr 2005

Technology helps Stanford shed new light on coronary bypass surgery

On March 31, Joel Dyels celebrated his 72nd birthday by having coronary bypass surgery at Stanford Hospital. He also became the third patient at Stanford - and in the United States - to benefit from a new imaging system that lets doctors see the blood pathways they have created while the patient's chest is still open.

12 Apr 2005

Colorectal Cancer News and Research

Latest Colorectal Cancer News and Research

Statin drugs prescribed for heart disease also reduce the risk of colon cancer

Risks outweigh benefits of shark cartilage as anti-cancer treatment

Cetuximab (Erbitux) can battle cancer and prolong life in many patients with advanced colorectal cancer

Sigmoidoscopy comes up short for women in detection of polyps in the colon

Smoking may have a devastating effect on gastrointestinal health

Statin chemoprevention with minimal surveillance could prevent 96 percent of colon cancers

Accuracy of CT colonography is excellent in comparison with conventional colonoscopy for colorectal cancer screening

Genetic biomarker that may improve quality of life during treatment for colorectal cancer

Bevacizumab plus chemo extends survival beyond one year for large group of advanced lung cancer patients

After surgery check colon tumors for signs of syndrome, study suggests

Scientists use tobacco plants to create antibodies against tumor cells

Gene variant that increases colon cancer risk

Blocking the COX-1 enzyme might be the answer in ovarian cancer treatment

Blocking the COX-1 enzyme might prevent and treat the most common and fatal form of ovarian cancer

Revised Bethesda guidelines effective at identifying patients at risk of colorectal cancer

Hereditary colorectal cancer risk lowered in those without certain gene defect

“Virtual Colonoscopy” effective in finding most polyps but may miss small ones

ASTRO public awareness campaign wins award

Researchers determine structure of binding site of colon-cancer drug Erbitux and its protein target

Technology helps Stanford shed new light on coronary bypass surgery

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Colorectal Cancer News and Research

Latest Colorectal Cancer News and Research

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Newsletters you may be interested in